Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
BIOSPECIFICS TECHNOLOGIES CORP (0000875622)
Standardized SEC financial data for BIOSPECIFICS TECHNOLOGIES CORP — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0000875622 · Pharmaceutical Preparations.
Operating margin
74.1%
Net margin
64.1%
Revenue growth (YoY)
15.9%
Return on equity
19.7%
Free cash flow
$22.3M
Current ratio
76.82×
EPS (diluted)
$3.33
Ratios for fiscal year 2019, standardized from SEC filings.